BridgeMD
New treatment option for Phantom Limb Pain After Amputation
Official title Preventing Chronification of Phantom Limb Pain Through Mirror Therapy in Conjunction With tDCS
ClinicalTrials.gov ID: NCT07139483
What this study is testing
- What it's testing
- Background: Most amputees experience phantom limb pain (PLP), for years after amputation. Virtually all PLP research to date has focused on the mechanisms of chronic PLP, ignoring the mechanisms of chronification.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥18);
- Amputation of a single limb ≤12 weeks ago; during this period of time, 80% of amputees develop PLP. Both upper and lower limb amputees are included...
- Acute PLP stage (2 weeks since first report), with intensity ≥3 on a 0-10 VAS;
- No change in medication in past week, excluding pro re nata analgesics;
- Can understand the study's purpose and instructions;
You likely can't join if
- Stump wound not healed;
- Other psychological, psychiatric, or neurological conditions;
- Contraindications for tDCS or magnetic resonance imaging (MRI) (MRI data will not be analyzed in the proposed PhD project), including previous...
- Inability to provide informed consent or understand or carry out the experiment.
See the full eligibility criteria
- Adults (age ≥18);
- Amputation of a single limb ≤12 weeks ago; during this period of time, 80% of amputees develop PLP. Both upper and lower limb amputees are included to increase feasibility;
- Acute PLP stage (2 weeks since first report), with intensity ≥3 on a 0-10 VAS;
- No change in medication in past week, excluding pro re nata analgesics;
- Can understand the study's purpose and instructions;
- Agrees to participate and to provide written informed consent.
- Stump wound not healed;
- Other psychological, psychiatric, or neurological conditions;
- Contraindications for tDCS or magnetic resonance imaging (MRI) (MRI data will not be analyzed in the proposed PhD project), including previous seizure, loss of consciousness due to head injury, metal in the head...
- Inability to provide informed consent or understand or carry out the experiment.
The study team makes the final eligibility decision.
Where it's taking place
- Raanana, Israel, Israel
- Tel Aviv, Israel, Israel
- Tel Aviv, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Raanana, Israel, Israel; Tel Aviv, Israel, Israel; Tel Aviv, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.